TrialEuropean journal of clinical pharmacology2024
The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer.
Ruggero Lasala et al.PubMed ↗Publisher ↗
No numbers read from the abstract.